Clinical Trial Update: UGX202 Injection in Patients With Advanced Retinitis Pigmentosa [EARLY_Phase 1]

View source ↗

Summary

This entry reports an early-phase 1 clinical trial of UGX202 in patients with advanced Retinitis Pigmentosa, with status not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Retinitis Pigmentosa

Drugs mentioned

• UGX202

Snippet

Sponsor: Suzhou UgeneX Therapeutics Co., Ltd. | Conditions: Retinitis Pigmentosa (RP) | EARLY_Phase 1 | Status: NOT_YET_RECRUITING